(Date:11/25/2009)...5/PRNewswire-USNewswire/--TheBlackAIDSInstituterec...iveleadershipfor2010. ,, ThenewBoardMembersarea...policy,law,finance,governmenthealthprograms,editor...romawiderangeofpersonalbackgroundsincludingbothhet...hemselves,andrepresentingmultipleagegroups. ,, ...
(Date:11/25/2009)...ndorsements,Business,andPressJoinEfforttoEducate ...-Onceagain,theNationalBipolarFoundationandtheMedic...Safe,tilStable"program,whichisnowbeingwidelyaccept....Today,theNationalBipolarFoundationreceivedaprocla...omtheLt.GovernorofLouisianaMitchLandrieu.TheNation...
(Date:11/25/2009)... evidence of a statistically significant survival ...se estrogen receptor (ER)-positive tumors had high...118 (ER-alpha S118-P), according to a brief commun...al of the National Cancer Institute . , Approxim...moxifen. Preclinical studies have shown that ER-al...
(Date:11/25/2009)...lood pressure? This simple question has been the ...ess-related gene Modulates High Blood Pressure in ... This simple question has been the focus of intens...or the first time established a link between a nov...e to stress in mice as well as humans. The studies...
(Date:11/25/2009)...to fight rheumatoid arthritis, could help newly di...SDAY, Nov. 25 (HealthDay News) -- A drug commonly ...d arthritis now also shows some promise in helping..., The drug, rituximab (Rituxan), helped patients ...ugh the disease had destroyed some of their pancre...
Breaking Medicine News(10 mins):Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3...e University of Michigan Health System say the fed...he elderly in a cost-effective manner that would u...eral government were to start a Flu vaccination pr...o are at a higher risk of death due to influenza v...
...sed by researchers at Medical College of Wisconsin... the improvement in survival rate in cardiac arres...study would be funded by the National Heart, Lung,...arrest and severe traumatic injury, and would be s...
...ical major Ranbaxy Laboratories Limited Friday ann...for asthma patients//.
"Ranbaxy has introduce...e is available in HFA (Hydroxy fluoro Alkane: the ...de HFA Inhaler, as opposed to the conventional CFC...
...d Health Organization (WHO), two fresh cases of po...another from Mudug region//, in southern Somalia a...s, with security-related restrictions, present a r... a total of 199 children to date, but which appear...
...study conducted by Theodore Blaine, M.D., assistan...versity Medical Center and an attending// surgeon ...te, a drug that is FDA-approved for osteoarthritis...ox-2 inhibitors. After that people went for surger...
...r of drug resistance TB is becoming apparent to th...t time. The Union Ministry is now pulling up// its...resistant MDR-TB.
DOTS Plus, or directly obs... Maharashtra and Gujarat. 100 MDR-TB cases are env...
Other Medicine News:Health News:Influenza Vaccination For The Elderly 2Health News:An Effective Drug Identified for Shoulder Pain 2(Date:11/25/2009)...5/PRNewswire/--Reportlinker.comannouncesthatanewma... IntranasalDrugDelivery-USMarketTrends&Analys...l-Drug-Delivery---US-Market-Trends--Analysis.html ...nganexpansionoftherapeuticapplicationsfromthedeliv...yofsystemictherapeuticdrugs.Thefutureofthetechnolo...
(Date:11/24/2009)...Nov.24/PRNewswire-Asia/--ChindexInternational,Inc....ricanproviderofWestern,healthcareproductsandservic...theCompanywillattendthe21stAnnualPiperJaffray,"Unp...09,atthe,NewYorkPalaceHotel. , Managementiscu...ember1,2009,andholdone-on-onemeetingsthroughoutthe...
(Date:11/24/2009)....,Nov.24/PRNewswire-FirstCall/--Vermillion,Inc.(VR...anofReorganizationandDisclosureStatementtoday,Nove...heDistrictofDelaware.Ahearingtoconsiderapprovaloft...er8,2009,withthehearingontheconfirmationofthePlans...Companytopayallclaimsinfull.ThePlanisexpected,ifap...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Chindex International to Present at Piper Jaffray Health Care Conference 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Music is the engine of new U M lab on a chip device 9321 1Music is the engine of new U M lab on a chip device 9321 2Stunting plants skyward reach could lead to improved yields 9318 1Stunting plants skyward reach could lead to improved yields 9318 2Public Health Experts Discuss Infectious Diseases Threats at News Conference 52432 1Public Health Experts Discuss Infectious Diseases Threats at News Conference 52432 2Public Health Experts Discuss Infectious Diseases Threats at News Conference 52432 3Public Health Experts Discuss Infectious Diseases Threats at News Conference 52432 4...ns for treating returning vets and others exposed ... Schepens Eye Research Institute have shown for th...ause both eyes to lose a special protective abilit...ects the eye without the inflammation of the body,... delicate eye tissue. This finding, published in t...
...ExonHit Therapeutics,(Alternext: ALEHT) is pleased... lead compound in Alzheimer,s disease, is progress...l assessing EHT 0202 in patients with,Alzheimer,s ...tion of patient enrolment for the Phase IIa,repres...EHT 0202, and,provides a clear timeline for the re...
Other Medicine Technology:Laser Burn Injuries in One Eye Can Disrupt Protective Immune Privilege in Both Eyes, Study Finds 2ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 2ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 3ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 4Naked Gold 20 nm
Naked Gold 20 nm - 50 OD
CranioFix2 Titanium Clamp System
...ate, reliable, portable, and easy-to-use pachymete... a dual-rechargeable battery system that makes cha...lution, color, touch screen controls make operatin...ent software simplifies calculating adjustments to...
Medicine Products: